Skip to main content
. 2020 Dec 1;10:20915. doi: 10.1038/s41598-020-77345-y

Figure 7.

Figure 7

Effects of ASP5878 in a patient-specific iPSC disease model for ACH. (a) Scheme showing the chondrogenic differentiation of ACH-iPSCs. After chondrogenic differentiation, the cells were transferred to suspension culture. ASP5878 or vehicle was added from day 15. Particles were subjected to analysis on day 84. ES, embryonic stem cell medium; MD mesodermal medium, Ch chondrogenic medium. (b) Results of a real-time RT-PCR expression analysis of marker genes. Three out of four independent experiments showed similar results. Error bars denote the means ± s.d. *P < 0.05; **P < 0.01 by the t-test. (c) Histology of the particles. Scale bars, 300 μm.